The FDA will review data to decide whether to approve MDMA, also known as ecstasy, for PTSD treatment. Biden is expected to issue an executive order addressing asylum seekers at the southern border.
, commonly known as ecstasy, to treat post-traumatic stress disorder. Some trial participants described the treatment as transformational. But the Institute for Clinical and Economic Review, a nonprofit that evaluates clinical trials, found"substantial concerns" about the validity of the study's results.
Initial results suggest that Prime Minister Narendra Modi of the BJP party will win a third term. If he's confirmed, he would be the only prime minister after the founder of modern India, Jawaharlal Nehru, to win three terms.That's because the party has fallen short of the super majority Modi promised, according to the tally so far. Hadid says this willand his party to continue their vast recasting of India as a country that elevates its Hindu majority above other citizens.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Psychedelic drug MDMA faces questions as FDA considers approval for PTSDFederal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of a decadeslong effort by advocates to move psychedelic drugs into the medical mainstream.
Read more »
Psychedelic drug MDMA faces questions as FDA considers approval for PTSDFederal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of a decadeslong effort by advocates to move psychedelic drugs into the medical mainstream.
Read more »
Psychedelic drug MDMA faces questions as FDA considers approval for PTSDThe drug application is part of a decade-long effort by advocates to move psychedelic drugs into the medical mainstream.
Read more »
Psychedelic drug MDMA faces questions as FDA considers approval for PTSDFederal health regulators are set to review the first request to approve the mind-altering club drug MDMA as a treatment for PTSD.
Read more »
Psychedelic drug MDMA faces questions as FDA considers approval for PTSDFederal health regulators are set to review the first request to approve the mind-altering club drug MDMA as a treatment for PTSD.
Read more »
Psychedelic drug MDMA faces questions as FDA considers approval for PTSDFederal health regulators are set to review the first request to approve the mind-altering club drug MDMA as a treatment for PTSD.
Read more »